Insurers Escape Allergy Treatment Groups' Antitrust Claims

By Matthew Perlman · November 28, 2023, 11:14 PM EST

A Louisiana federal court has tossed antitrust claims from allergy testing and immunotherapy outfits against Blue Cross Blue Shield of Louisiana and other insurers after finding a lack of evidence showing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Academy of Allergy & Asthma in Primary Care et al v. Louisiana Health Service and Indemnity Company et al

Case Number

Court

Louisiana Eastern

Nature of Suit

Anti-Trust

Date Filed

January 12, 2018

Recent Articles By Matthew

April 14, 2025
Takeda Gets Actos Case Paused For Class Cert. Review
April 07, 2025
Monthly Merger Review Snapshot
April 02, 2025
Serial Acquisitions Are Still On The FTC's Radar
April 01, 2025
Takeda Antitrust Trial Over Actos Generics Set For July
March 28, 2025
PE Firm Hits Back Against Medical Device Coating Challenge
March 27, 2025
DOJ's Antitrust Unit Targeting Anticompetitive Regulations
March 20, 2025
8th Circ. Won't Pause FTC's Insulin Pricing Case
March 17, 2025
Court Won't Toss Biotech Co.'s Antitrust Counterclaim
March 14, 2025
FTC Urges 8th Circ. Not To Pause Insulin Pricing Case
March 13, 2025
Calif. AG Appealing State Limits On Pay-For-Delay Ban